Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
grade C 22.56 -0.09% -0.02
BHC closed down 0.09 percent on Wednesday, October 23, 2019, on 61 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical BHC trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Inside Day Range Contraction -0.09%
Overbought Stochastic Strength -0.09%
MACD Bullish Centerline Cross Bullish -1.31%
Pocket Pivot Bullish Swing Setup -1.31%
Overbought Stochastic Strength -1.31%
Overbought Stochastic Strength 0.09%
Pocket Pivot Bullish Swing Setup -1.05%

Older signals for BHC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
Biotechnology Life Sciences Organ Systems Laser S&P/Tsx 60 Index Psoriasis Medical Devices Acne Specialty Drugs Ulcerative Colitis Atopic Dermatitis Diarrhea Irritable Bowel Syndrome Generic Pharmaceuticals Hair Removal Over The Counter Products Salix Pharmaceuticals Bausch Health Eye Health Products
Is BHC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 27.72
52 Week Low 17.2
Average Volume 3,348,874
200-Day Moving Average 23.3119
50-Day Moving Average 21.6014
20-Day Moving Average 20.906
10-Day Moving Average 21.765
Average True Range 0.7524
ADX 26.49
+DI 28.3589
-DI 16.4045
Chandelier Exit (Long, 3 ATRs ) 20.8628
Chandelier Exit (Short, 3 ATRs ) 20.9772
Upper Bollinger Band 23.7727
Lower Bollinger Band 18.0393
Percent B (%b) 0.79
BandWidth 27.424663
MACD Line 0.2497
MACD Signal Line -0.1061
MACD Histogram 0.3558
Fundamentals Value
Market Cap 7.87 Billion
Num Shares 349 Million
EPS -3.27
Price-to-Earnings (P/E) Ratio -6.90
Price-to-Sales 0.44
Price-to-Book 1.03
PEG Ratio -0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.97
Resistance 3 (R3) 22.96 22.82 22.90
Resistance 2 (R2) 22.82 22.72 22.82 22.87
Resistance 1 (R1) 22.69 22.65 22.76 22.70 22.85
Pivot Point 22.55 22.55 22.58 22.55 22.55
Support 1 (S1) 22.42 22.45 22.49 22.43 22.27
Support 2 (S2) 22.28 22.38 22.28 22.25
Support 3 (S3) 22.15 22.28 22.22
Support 4 (S4) 22.16